LGALS2 suppresses the progression of papillary thyroid carcinoma by regulating the PI3K/AKT pathway

CONCLUSIONS: These data indicate that LGALS2 suppresses PTC progression via PI3K/AKT pathway activation, suggesting that LGALS2 offers value as a treatment target for patients with this cancer type.PMID:36221286 | PMC:PMC9547712 | DOI:10.21037/gs-22-452

Source: Cancer Control - October 12, 2022 Category: Cancer & Oncology Authors: Debin Xu Liangyun Guo Shuyong Zhang Qian Hou Source Type: research